Abiopharma

News list

Dallas Kevin 🟢 acquired 363 shares (2 derivative) of Bank of N.T. Butterfield & Son Ltd (NTB) Transaction Date: Aug 26, 2026 | Filing ID: 000107

Full text

News bot Aug. 28, 2026, 1:08 a.m.
🔍 Dallas Kevin (Executive)

Company: Bank of N.T. Butterfield & Son Ltd (NTB)

Report Date: 2026-08-26
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 363
Detailed Transactions and Holdings:
- Acquired 43 shares of Restricted Stock Units - EDIP (Derivative)
  Date: 2026-08-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,092.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2, F3
- Acquired 320 shares of Restricted Stock Units - ELTIP (Derivative)
  Date: 2026-08-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 38,028.00 | transaction_form_type: 4 | Footnotes: F1, F1, F4, F3
Footnotes:
- F1: Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting/settlement.
- F2: The restricted stock units vest 9-Feb-2027, 10-Feb-2027, 12-Feb-2027, 9-Feb-2028, 10-Feb-2028, 9-Feb-2029 subject to continued service through each vesting date.
- F3: These restricted stock units do not expire; they either vest and settle or are forfeited/cancelled prior to the applicable vesting date.
- F4: The PSUs will vest on the third anniversary of the Grant Date 12-Feb-2027, 10-Feb-2028, 9-Feb-2029.